SCHEMBL30890635

SCHEMBL30890635

CN[C@@H](CC1CC1)C(=O)N1CC2(C[C@H]1C(N)=O)Oc1nc(C)ccc1NC2=O

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ OTUD7B Q6GQQ9 5/20 0.32
▸ F2 P00734 1/20 0.32
▸ CNR2 P34972 7/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30890405 0.87 CNR2 (0.33) F2CNR2
SCHEMBL27244982 0.85 OTUD7B (0.30) OTUD7B
SCHEMBL27244994 0.85 OTUD7B (0.30) OTUD7B
SCHEMBL27244806 0.85 OTUD7B (0.31) OTUD7BCNR2
SCHEMBL27244836 0.85 OTUD7B (0.31) OTUD7BCNR2
SCHEMBL27245178 0.85 F2 (0.34) OTUD7BF2CNR2
SCHEMBL30890618 0.85 F2 (0.34) OTUD7BF2CNR2
SCHEMBL27245189 0.85 F2 (0.34) OTUD7BF2CNR2
SCHEMBL27245114 0.83 CNR2 (0.31) CNR2
SCHEMBL27245121 0.83 CNR2 (0.31) CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612156-A1 ANTI-VIRAL COMPOUNDS Aligos Therapeutics, Inc. (US) 2025-09-10 — — EP disclosed
WO-2024097296-A1 ANTI-VIRAL COMPOUNDS ALIGOS THERAPEUTICS, INC. (US) 2024-05-10 — — WO disclosed
Send feedback